Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)

Part of paid clinical trials in Charlestown, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT05354232
Status
Recruiting
Apply to this trial

Conditions

  • Attention Deficit Disorder
  • Attention Deficit Disorder With Hyperactivity

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • 2 mA transcranial direct current stimulation (tDCS) — DEVICE
    tDCS is a non-invasive neuromodulatory technique that has previously demonstrated the ability to transiently modulate cognitive domains in both healthy and psychiatric populations. In the 2mA condition, the investigators will assist the administration of a 2mA current stimulation from the device.
  • 1 mA transcranial direct current stimulation (tDCS) — DEVICE
    tDCS is a non-invasive neuromodulatory technique that has previously demonstrated the ability to transiently modulate cognitive domains in both healthy and psychiatric populations. In the 1mA condition, the investigators will assist the administration of a 1mA current stimulation from the device.
  • Sham transcranial direct current stimulation (tDCS) — DEVICE
    tDCS is a non-invasive neuromodulatory technique that has previously demonstrated the ability to transiently modulate cognitive domains in both healthy and psychiatric populations. In the sham condition, the investigators will assist the administration of a sham stimulation from the device.

Study Details

The investigators are investigating whether home-based tDCS over the course of four weeks can improve ADHD symptom severity and improve dysexecutive functioning (cognitive control). Further, the investigators are investigating whether there is a dose-dependent response to tDCS.

Key Dates

Start date
Jul 1, 2022
Status verified
Dec 2025
Primary completion
May 31, 2026
Completion
May 31, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: 2mA transcranial direct current stimulation
  • Experimental: 1mA transcranial direct current stimulation
  • Sham Comparator: Sham transcranial direct current stimulation

Primary Outcome Measure

P300 Amplitude during Erickson Flanker Task [ Time Frame: Week 1 - Week 8 of Study ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Massachusetts General HospitalCharlestownMassachusetts02129
DNN Inbox
[email protected]
6177268780

Find similar trials in Charlestown, MA

By research site
Massachusetts General Hospital· Charlestown, MA

Related Studies